# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Florence Nightingale (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI004-SYN
- Date: 2026-03-02
- Fictional facility: St. Posthumous Health Center
- Fictional author: Isobel Marchetti, MD
- Calendar frame: modern shifted

## Subjective

The patient participates in this fictional visit for new patient visit for nearly three years of exhausting fatigue that worsens after exertion. **S**

## Objective

Hemoglobin: 12.9 g/dL; White cell count: 5.8 10*3/uL; Platelets: 246 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.72 mg/dL; eGFR: 110 mL/min/1.73 m²; Glucose: 86 mg/dL; Calcium: 9.3 mg/dL; Albumin: 4.3 g/dL; ALT: 16 U/L; AST: 19 U/L; Alkaline phosphatase: 68 U/L; Total bilirubin: 0.6 mg/dL; Phosphate: 3.6 mg/dL; ESR: 8 mm/h; CRP: 1.2 mg/L; TSH: 1.9 mIU/L; HbA1c: 5.1%; Ferritin: 48 ng/mL; Tissue transglutaminase IgA: 1 U/mL; Creatine kinase: 92 U/L; Morning cortisol: 14.2 ug/dL; Vitamin B12: 410 pg/mL; Folate: 12.4 ng/mL; 25-hydroxyvitamin D: 17 ng/mL (low); PHQ-9: 8; GAD-7: 5; PROMIS fatigue T-score: 71; PROMIS physical function T-score: 32; Pain score (0 to 10): 4. All results are synthetic.

BP 104/66 mmHg; pulse 78 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 55 kg; BMI 19 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Myalgic encephalomyelitis/chronic fatigue syndrome, post-infectious, moderate severity, with orthostatic intolerance; synthetic modern diagnosis by NICE and IOM criteria, linked to her documented Crimean fever and decades of illness, which are only retrospectively and disputedly read as ME/CFS; Personal history of brucellosis diagnosed by serology during an overseas field-hospital deployment and treated with six weeks of doxycycline and rifampin; no evidence of relapse. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Continued without change: Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a day **S**

## Plan

- Diagnose ME/CFS by clinical criteria after exclusion tests, explain that it is a real illness with no diagnostic test, and give her a written care and support plan, including a flare plan. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024) **S**
- Energy management led by the patient: an activity and symptom diary, planned rest before and between tasks, work broken into short blocks, and heart-rate awareness; no graded exercise therapy or fixed increases in activity. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024); Grach SL, et al. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 2023;98(10):1544-1551 (2023) **S**
- Infectious diseases consultation to look for relapsed or focal brucellosis or another persisting infection before attributing her symptoms to ME/CFS. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Clinical Overview of Brucellosis (2024); Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005;352(22):2325-2336 (2005) **S**
- Orthostatic intolerance measures: 2 to 2.5 L of fluid a day, more salt with meals, waist-high compression garments, and tasks done seated or reclined; repeat the standing test at six months. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Grach SL, et al. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 2023;98(10):1544-1551 (2023) **S**
- Sleep, pain, and cognitive symptom care: a regular sleep window with rest periods kept short, acetaminophen as needed, no sedatives or opioids, and memory aids for work. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024) **S**
- Review the care plan at every visit, with PHQ-9, PROMIS fatigue and physical function scores, and a pain score; primary care review at least yearly and more often while the plan is new. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021) **S**
- Workplace adjustments: home working, a reclined workstation, flexible hours, and meetings by video or at her home. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024) **S**
